1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Coronary Thrombosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bush, CA; Pfahl, KW; Wright, NR | 1 |
Asada, Y | 1 |
Willerson, JT | 1 |
Cui, K; Gaskell, SJ; Haught, CA; Johnston, DA; McNatt, JM; Mueller, HW; Willerson, JT | 1 |
Ambrosio, G; Buja, LM; Chiariello, M; Condorelli, M; Golino, P; McNatt, J; Oriente, A; Pascucci, I; Ragni, M; Triggiani, M | 1 |
Abendschein, DR; Bergmann, SR; Haskel, EJ; Torr, SR; VonVoigtlander, PF | 1 |
Homeister, JW; Jackson, CV; Lucchesi, BR; Mickelson, JK | 1 |
3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Coronary Thrombosis
Article | Year |
---|---|
[Inflammatory and immune responses in arterial thrombus formation].
Topics: Acute Disease; ADAM Proteins; ADAMTS13 Protein; Autoantibodies; Cell Adhesion Molecules; Coronary Thrombosis; Cytokines; Humans; Inflammation Mediators; Platelet Activating Factor; Purpura, Thrombotic Thrombocytopenic | 2005 |
Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products.
Topics: Animals; Blood Coagulation Factors; Blood Platelets; Coronary Artery Disease; Coronary Circulation; Coronary Thrombosis; Endothelium, Vascular; Humans; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Vasoconstriction | 1995 |
Interaction of the formed elements of blood with the coronary vasculature in vivo.
Topics: Animals; Blood Cells; Coronary Disease; Coronary Thrombosis; Coronary Vessels; Dogs; Endothelium; Free Radicals; Leukocytes; Oxygen; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction; Vasodilation; Xanthine Oxidase | 1987 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Coronary Thrombosis
Article | Year |
---|---|
Purulent Pericarditis and Abscessed Myocardium with Acute Myocardial Infarction.
Topics: Abdominal Pain; Abscess; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cardiac Catheterization; Coronary Thrombosis; Drug-Eluting Stents; Dyspnea; Electrocardiography; Fatal Outcome; Female; Heart; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Pericardiocentesis; Pericarditis; Platelet Activating Factor; ST Elevation Myocardial Infarction; Tachycardia, Sinus; Urinary Tract Infections | 2016 |
Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease.
Topics: Animals; Biological Assay; Chromatography, Gas; Chromatography, High Pressure Liquid; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Coronary Vessels; Dogs; Endarterectomy; Humans; In Vitro Techniques; Male; Mass Spectrometry; Platelet Activating Factor; Rabbits; Radioimmunoassay; Time Factors | 1995 |
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Topics: Animals; Blood Flow Velocity; Carotid Artery Thrombosis; Coronary Thrombosis; Diterpenes; Dogs; Female; Ginkgolides; Lactones; Leukocytes; Male; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Rabbits; Regional Blood Flow; Time Factors | 1993 |
Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor.
Topics: Administration, Oral; Animals; Benzodiazepines; Bleeding Time; Blood Coagulation; Blood Flow Velocity; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Therapy, Combination; Hemodynamics; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prothrombin Time; Recurrence; Tissue Plasminogen Activator; Triazolam; Triazoles | 1991 |